General description
Glycopyrrolate is a quaternary ammonium compound and it shows structural similarity with atropine.
Biochem/physiol Actions
Glycopyrrolate is an anti-cholinergic drug. It is a potent controller of drooling, observed in children affected with cerebral palsy. Compared to other muscarinic antagonists, glycopyrrolate has lower CNS (central nervous system) penetration.
Glycopyrrolate is long-acting muscarinic antagonist (LAMA). It is kinetically selective muscarinic M3 receptor antagonist.
Features and Benefits
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 51151611
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML0029-25MG
- CAS:
- 596-51-0
akash.verma@cenmed.com
(732) 447-1115





